121 results on '"Krausewitz, Philipp"'
Search Results
2. Multiparametrische MRT und alternative Methoden in der Interventions- und Behandlungsplanung beim Prostatakarzinom
3. Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer
4. Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study
5. Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center
6. Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis
7. Klinische Aspekte bei der Diagnose und Therapie des Prostatakarzinoms
8. Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients’ expectancy?
9. MP61-08 TROP-2—A PROMISING NEW THERAPEUTIC TARGET IN PENILE SQUAMOUS CELL CARCINOMA
10. Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
11. Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy
12. Exploring membranous NECTIN‐4 expression patterns and enfortumab vedotin response in prostate cancer.
13. Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer.
14. Klinische Aspekte bei der Diagnose und Therapie des Prostatakarzinoms
15. The relevance of circRNAs in serum of patients undergoing prostate biopsy
16. Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
17. Emotion‐centered versus fact‐centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial
18. Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer.
19. Emotion‐centered versus fact‐centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial.
20. Diagnostic et définition des stades du cancer de la prostate métastatique hormonosensible
21. Prostate cancer—multiparametric MRI and alternative approaches in intervention and therapy planning
22. Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI
23. Trop-2: A promising new therapeutic target in penile squamous cell carcinoma.
24. Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
25. Diagnosis and staging of metastatic hormone-sensitive prostate cancer
26. Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study
27. Kommentar zu: Prostatakarzinom: PSMA-PET besser als konventionelles Staging.
28. DEPROMP Trial: The additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men – study protocol for a randomized controlled trial
29. Omitting routine cystography after RARP: Analysis of complications and readmission rates in suprapubic and transurethral drained patients
30. Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
31. Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment
32. Fungaemia caused by obstructive renal candida bezoars leads to bilateral chorioretinitis: a case report
33. Omitting routine cystography after RARP: Analysis of complications and readmission rates in suprapubic and transurethral drained patients.
34. Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
35. Prä-, intra- und postoperative Einflussfaktoren funktioneller Einschränkungen nach radikaler Prostatektomie
36. Influence of sample preparation and reliability of automated numerical refocusing in stain-free analysis of dissected tissues with quantitative phase digital holographic microscopy
37. Analysis of dissected tissues with digital holographic microscopy: quantification of inflammation mediated tissue alteration, influence of sample preparation, and reliability of numerical autofocusing
38. Quantitative Stain-Free and Continuous Multimodal Monitoring of Wound Healing In Vitro with Digital Holographic Microscopy
39. Digital Holographic Microscopy to Assess Inflammation in Crohnʼs Disease and to Monitor Intestinal Wound Healing In vitro
40. Quantification of inflammation in colonic tissue sections and wound healing in-vitro with digital holographic microscopy
41. Su1177 Towards Stain-Free and Automatized Analysis of Experimental Colitis and Intestinal Wound Healing In Vitro by Digital Holographic Microscopy
42. Digital holographic microscopy quantifies the degree of inflammation in experimental colitis
43. Digital Holographic Microscopy for Assessment of Experimental Colitis and Monitoring of Intestinal Wound Healing in vitro
44. Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma.
45. Influence of sample preparation and reliability of automated numerical refocusing in stain-free analysis of dissected tissues with quantitative phase digital holographic microscopy
46. Analysis of dissected tissues with digital holographic microscopy: quantification of inflammation mediated tissue alteration, influence of sample preparation, and reliability of numerical autofocusing
47. Quantification of inflammation in colonic tissue sections and wound healing in-vitro with digital holographic microscopy
48. Regional cerebral blood flow is compromised during robotic surgery in the Trendelenburg position, but not during surgery in the beach chair position: an observational study.
49. Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
50. Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.